You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RXRX Disposition Disclosure
Khan Najat · SEC Form 4 · Filed Aug 18, 2026
Disposition
Calculated transaction value
$254.37K
Khan Najat CEO And President
RXRX
Transaction date
Aug 17, 2026
Public filing date
Aug 18, 2026
Filing lag
Filed 1 day later
RXRX daily price context
Close on/before transaction
$3.11
Aug 17, 2026
First close after public filing
$3.5
Aug 19, 2026
30-day return after filing
+1.14%
Through Sep 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 80,498 shares @ $3.16
- SEC ownership
- Direct
- Transaction code
- F
- Form
- 4
- Filing identifier
- 0002020969-26-000006
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$254.37K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Recursion Pharmaceuticals, Inc. RXRX Current | Disposition | Aug 17, 2026 | $254.37K |